Press Release

Session 2008-09, 23 October 2009

Oral Evidence


Tuesday 27 October 2009, 10.30am

Room 6, Palace of Westminster

This is the fourth evidence session in the Committee's inquiry into the Cocaine Trade. The session will explore further the nature of cocaine addiction, treatment options, and treatment provision in both the public and private sector. It will also explore drug classification and the independent research and advice available to Government in policymaking.

The Committee is taking evidence from:

At 10.30 am

€ Paul Hayes, Chief Executive, National Treatment Agency for Substance Misuse

€ John Jolly, Chief Executive, Blenheim Community Drug Programme

€ Dr Nick Brener, Addictions specialist, The Priory clinic

At approximately 11.15 am

€ Professor David Nutt, Chair, Advisory Council on the Misuse of Drugs

€ Dr Fiona Measham, Member, Advisory Council on the Misuse of Drugs

Rt Hon Keith Vaz MP, Chairman of the Committee, said:

"Having heard last week about the devastating impact of drug dependency on users and their families, we relish the opportunity today to examine in detail treatment options for cocaine and investigate whether Government funds are reaching those who need them most. To that end we are pleased to hear from representatives of both public and private sector drug rehabilitation services."

"We also look forward to discussing drug classification and research with Professor Nutt, Chair of the independent Advisory Council on the Misuse of Drugs".